Now Reading
Magic Mushrooms for Stress and Migraines

Magic Mushrooms for Stress and Migraines

Migraines are a medical condition found in nearly 1 in 4 households in America (the writer of this piece is 1 of those 4). 18% of women, 6% of men, 10% of children in America experience migraines (both the author and Microdose. Buzz are not advocating or suggesting that children should consume/consider psilocybin). Migraines are considered a very common chronic condition that can last for years or a lifetime, and according to the Migraine Foundation, migraines are the 3rd most prevalent illness in the world. 

Types of Migraine and Causes 

Photo: Courtesy of The Guardian

There are multiple migraine types. They have some of the same symptoms but also differ:

  • Migraine with aura
  • Migraine without aura
  • Chronic Migraine
  • Migraine with brainstem aura
  • Vestibular migraine
  • Abdominal migraine 
  • Hemiplegic migraine
  • Menstrual migraine
  • Cyclical migraine 
  • Medication overuse headache 

The cause of migraine can be many things like stress, hormonal, and/or weather changes. Treatments for migraine are reported as: 

“Medications used to combat migraines fall into two broad categories: Pain-relieving medications: also known as acute or abortive treatment, and preventive medications: taken regularly, often daily, to reduce the severity or frequency of migraines.”

Western medicine criminalized nature, and because of that, lab-made treatments are the only documented source for migraine treatment, until now. With the legalization of psilocybin in various cities and states around the country, migraine and psilocybin research is now being released.

Psilocybin Treatment for Migraine

Photo Credit: Third Wave 

Psilocybin decriminalization and legalization have heightened the coverage for psilocybin as a potential medicine for many conditions. A search for “psilocybin and migraine” provides a multitude of resources with insight like:

  • “Schindler and her colleagues found that psilocybin was associated with a greater reduction in the frequency of migraines.”
  • “A new small scale study reveals psilocybin appears to have a beneficial effect for chronic migraine sufferers.”
  • “An exploratory study has found a single dose of the psychedelic psilocybin can reduce migraine frequency by 50 percent for at least two weeks.”

Though prohibited and on the DEA’s list of Schedule I “drugs,” the U.S National Library of Medicine, National Health Institutes state the following about psilocybin for migraines:

“Overall, LSD and psilocybin were reported as highly effective for both CH (cluster headaches) and migraines. Both substances were reportedly effective for prophylactic as well as acute treatment.”

In Closing

Here’s a quick dive into what research is saying about psilocybin as treatment for migraines:

  • New Atlas News reports the following from a study  conducted by Yale School of Medicine researchers: “the preliminary trial was small, but the promising findings suggest a potential for psychedelics to treat migraines.”
  • MAPS reports the following from New York Magazine, which explored scientific research on psilocybin and headaches: “Over 50 percent of the subjects studied revealed that one dose of psychedelics caused total cessation of their headaches, while about a quarter said that the drug aborted a headache mid-attack.”
  • The Growth Op reports the following from a study published in the journal Neurotherapeutics: “there is an enduring therapeutic effect in migraine headaches after a single administration of psilocybin.”

The above are research findings and do not include active research/ studies regarding psilocybin for migraine treatment. In places like Oregon, California, and Denver, we will begin to see more insight and information regarding psilocybin treatment for migraines. These states have legalized and/or decriminalized the consumption of psychedelics for medicinal use. Research shows that it’s time to decriminalize nature. 

See Also

This is a repurposed version of the original article- written by the author- and published in Microdose.Buzz, your guide to the business of psychedelics. 


Author: Veronica Castillo, a Writer from Miami, with a pre-Cannabis and Psychedelics industries background in insurance and human resources. Currently, she is a resident of the road covering cannabis, psychedelics, and plant lifestyles all over the U.S and soon abroad.



Feature Photo Credit: Third Wave